Jaundice is extremely common in newborns, affecting about 60% of term infants and 80% of preterm infants during the first week of life. In adults, it is uncommon, occurring in perhaps 1% to 3% of hospitalized patients and reflecting an underlying disorder rather than a normal transition.
The word jaundice describes the yellowing of skin and sclera caused by bilirubin deposition. Bilirubin is the end product of heme breakdown, produced when red blood cells are recycled. The frequency of jaundice is therefore not a single fact but a function of age, physiology, and the underlying cause. This explainer reconciles the ranges you will encounter, explains the mechanisms that drive the age difference, and provides practical thresholds for recognizing when yellowing signals something serious.
Bilirubin metabolism and why jaundice occurs
Heme is released when red blood cells are destroyed and is converted to unconjugated bilirubin. This form is lipid-soluble and travels bound to albumin in the bloodstream. The liver conjugates it with glucuronic acid, making it water-soluble and excretable in bile. Jaundice appears when bilirubin production outpaces clearance, when conjugation is impaired, or when bile flow is obstructed.
Unconjugated hyperbilirubinemia is the chemistry of overproduction or impaired liver uptake. Conjugated hyperbilirubinemia is the chemistry of cholestasis, meaning bile cannot leave the liver or where it should flow. The distinction matters because the two categories have different causes and different urgency. A clinician who sees yellow skin must first determine which pattern is present.
The sclera is the earliest visible site because it is rich in elastin, which binds bilirubin with high affinity. Skin yellowing follows once serum levels rise further. This is why conjunctival inspection is a sensitive screening maneuver in both infants and adults.
How common is jaundice in newborns?
Newborn jaundice is best described as a near-universal physiologic transition that becomes pathologic in a minority. Visible jaundice appears in roughly 60% of term infants and 80% of preterm infants within the first week. Serum bilirubin rises in nearly all newborns, so the clinically meaningful question is not whether it occurs but whether it crosses treatment thresholds.
The physiology explains the frequency. Newborns have a larger red blood cell mass per kilogram and shorter red cell lifespan, so heme turnover is high. Their hepatic conjugation enzymes mature over days to weeks, so clearance lags. Enterohepatic circulation is also more active, meaning bilirubin that reaches the gut is reabsorbed rather than excreted.
Peak levels are typically reached between day 3 and day 5 in term infants and later in preterm infants. Levels above 95th percentile for age in hours warrant evaluation per major pediatric guidance. The practical takeaway is that yellowing in the first 24 hours is never physiologic and always warrants prompt assessment.
How common is jaundice in adults?
Adult jaundice is uncommon in the general population but common among specific inpatient groups. Community prevalence is not well captured by broad surveys because jaundice is a sign, not a diagnosis, and reporting depends on the underlying disease. In hospitalized patients, estimates in the range of 1% to 3% appear in clinical literature. These numbers should be treated as approximate because ascertainment varies by setting.
The dominant causes in adults differ by pattern. Unconjugated hyperbilirubinemia suggests hemolysis, impaired hepatic uptake, or conjugation defects such as Gilbert syndrome. Conjugated hyperbilirubinemia suggests hepatocellular injury or biliary obstruction. In adults, obstruction from gallstones or malignancy and hepatocellular disease from alcohol, viral hepatitis, or metabolic dysfunction are leading categories.
Gilbert syndrome deserves specific mention. It affects roughly 5% to 10% of populations of European descent and causes mild, intermittent unconjugated hyperbilirubinemia. It is benign and typically produces bilirubin levels below 3 mg/dL. Many people with the genotype never notice yellowing at all.
Age-stratified comparison of jaundice patterns
| Feature | Newborn (term) | Newborn (preterm) | Adult (unconjugated) | Adult (conjugated) |
|---|---|---|---|---|
| Approximate frequency | 60% visible | 80% visible | Uncommon; Gilbert in 5-10% of some populations | Uncommon overall |
| Typical peak timing | Day 3-5 | Day 5-7 or later | Variable, often chronic mild | Depends on cause |
| Dominant mechanism | Immature conjugation, high heme turnover | Same, more pronounced | Hemolysis or conjugation defect | Hepatocellular injury or obstruction |
| Typical bilirubin range | Often 5-12 mg/dL | Can exceed term levels | Usually under 3 mg/dL in Gilbert | Variable, often higher |
| Urgency | Time-dependent thresholds | Lower thresholds | Usually outpatient | Often urgent evaluation |
| Key first step | Measure bilirubin by age in hours | Measure and risk-stratify | Fractionate bilirubin | Fractionate and image |
The table makes the central point explicit: the same word describes a routine transition in one age group and a diagnostic signal in another. Frequency alone does not capture clinical meaning.
Red flags and edge cases that change the calculus
Several presentations move jaundice from common to urgent. These warrant same-day assessment rather than watchful waiting.
Jaundice visible within the first 24 hours of life, which suggests hemolysis or infection. Jaundice persisting beyond two weeks in term infants or three weeks in preterm infants. Pale stools or dark urine in an infant, suggesting cholestasis. Rapidly rising bilirubin or levels approaching age-specific treatment thresholds. Jaundice with fever, abdominal pain, or altered mental status in an adult. Painless jaundice with weight loss in an adult, which raises concern for malignancy.
The counterintuitive detail is that visible jaundice underestimates serum bilirubin in some infants and overestimates it in others. Visual assessment alone is unreliable, which is why transcutaneous or serum measurement is standard. A clinician’s impression of “just a little yellow” is not a substitute for a number.
Another edge case is breast milk jaundice, which appears after the first week and can persist for weeks. It is distinct from breastfeeding failure jaundice, which occurs earlier and reflects inadequate intake. The two have different management implications despite similar appearances.
Misconceptions about frequency and severity
A common misconception is that newborn jaundice is always harmless because it is so common. Frequency and safety are separate questions. Most newborn jaundice resolves without treatment, but a small fraction progresses to levels where intervention prevents harm. The correct frame is risk stratification, not reassurance by prevalence.
A second misconception is that adult jaundice is usually harmless because Gilbert syndrome exists. Gilbert is common but benign, while the other causes of adult jaundice are not. Assuming a benign cause without fractionating bilirubin and evaluating the liver is a recognized source of delayed diagnosis.
A third misconception is that yellow skin and yellow eyes are interchangeable signs. Scleral icterus tends to appear before generalized skin yellowing and is more reliable on inspection. Skin color alone is affected by lighting, perfusion, and skin tone, which reduces its accuracy.
Practical actions and thresholds
For newborns, the actionable step is measurement rather than visual judgment. Bilirubin should be interpreted against age in hours, not against a single fixed cutoff. Treatment thresholds vary by gestational age, postnatal age, and risk factors, and they are defined in major pediatric guidance rather than in a single universal number. Parents should seek assessment for jaundice in the first 24 hours, worsening yellowing, poor feeding, or lethargy.
For adults, the actionable step is fractionation. Total bilirubin should be split into direct and indirect components, and the pattern should guide the workup. Unconjugated predominance points toward hemolysis or a conjugation defect. Conjugated predominance points toward hepatocellular or biliary disease and often requires imaging.
Practical thresholds worth remembering are approximate and should be applied with clinical context. Gilbert syndrome typically produces unconjugated bilirubin under 3 mg/dL. Newborn levels above the 95th percentile for age in hours warrant evaluation. Any adult with conjugated hyperbilirubinemia needs a cause identified rather than observed.
Limits of the evidence and what remains uncertain
Precise population frequencies for adult jaundice are genuinely uncertain. Most published figures come from hospital series rather than community sampling, so they describe the sickest patients rather than the general population. Reporting also depends on how jaundice is defined, whether by inspection, by bilirubin threshold, or by diagnosis code.
Newborn frequencies are better established because universal screening generates structured data. Even there, estimates vary with gestational age, feeding method, and the threshold used to define visible jaundice. The 60% and 80% figures are widely cited and internally consistent, but they describe visible jaundice rather than treatment-requiring hyperbilirubinemia.
The honest summary is that frequency answers differ by age and by definition. Newborn jaundice is a routine physiologic event. Adult jaundice is an uncommon sign that should prompt a structured search for cause. Treating those two facts as one statistic is the most common error in thin explanations of this topic.